Christopher Capelli - 11 Aug 2025 Form 4 Insider Report for Autonomix Medical, Inc. (AMIX)

Role
Director
Signature
/s/ Trent Smith, Attorney-in-Fact for Christopher Capelli
Issuer symbol
AMIX
Transactions as of
11 Aug 2025
Net transactions value
$0
Form type
4
Filing time
13 Aug 2025, 21:16:29 UTC
Previous filing
26 Jan 2024
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Capelli Christopher Director 21 WATERWAY AVENUE, SUITE 300, THE WOODLANDS /s/ Trent Smith, Attorney-in-Fact for Christopher Capelli 13 Aug 2025 0001768585

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AMIX Option (Right to buy) Disposed to Issuer -3,750 -100% 0 11 Aug 2025 Common Stock 3,750 $40.00 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option represents a revised share amount and exercise price based on a 1-for-20 reverse stock split from October 25, 2024. The option was cancelled by mutual agreement of the reporting person and the Company. The reporting person received no consideration for the cancellation.